DS9 Document EFTA01184956

it.. 10 10 k O 0 111% Contact Information & Disclaimer Harvard Square, One Mifflin Place, Suite 400 Cambridge, MA 02138 Tel: (617) 674-7718 Fax: (617) 674-7701 www.Aurorabiopharma.net \ -- --1" Statements made in this presentation regarding Aurora Biopharma, Inc. ("Aurora" or the "Company.") are not historical facts, they - (.) are forward looking statements based on estimates and projections. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995• It is being provided for informational ptnposes only, and should not be relied upon on its own. Statements that describe the Company's future plans, objectives ol• goals in this press release are" forvvard-looking statements". These forward-looking statements can be identified as including words such as "expects," "should," "believes," "anticipates" or words of similar import. Such forward-looking statements are subject to certain risks and uncertainties, including the ability to obtain needed fmancing, which could cause actual results to differ from those anticipated. We cannot provide any assurance that such forward-looking statements re• expectations will be fulfilled. The Company undertakes no obligation to update publicly any forward-looking statements for any reason. EFTA01184956